December 4, 2024

Upfront treatment and early intervention to get attention at ASH 2024, including mantle cell lymphoma with the striking results of study EA4151

November 26, 2024

WATCH: David Schiff discusses the striking survival improvement for patients with low-grade brain tumors found in study E3F05

October 30, 2024

ECOG-ACRIN and Caris partner to learn more from the TAILORx trial

October 30, 2024

WATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow

October 29, 2024

WATCH: Breast Cancer Research Foundation hosts Dr. Joseph Sparano and Amanda Quick of The Pink Agenda to discuss metastatic breast cancer

October 25, 2024

ECOG-ACRIN Lymphoma Committee co-chair Andrew Evens comments on the results of the SWOG study S1826, Nivolumab-AVD in Advanced-Stage Classic Hodgkin Lymphoma

October 25, 2024

ECOG-ACRIN and Caris to analyze samples from TAILORx (requires free registration)

October 15, 2024

Cooperative groups develop consensus nomenclature for radiation targets on future lymphoma clinical trials

October 11, 2024

Journal of Clinical Oncology publishes RTOG 1106/ACRIN 6697 results: Midtreatment PET-adapted radiotherapy dose escalation fails to improve outcomes for lung cancer patients

ECOG-ACRIN Cancer Research Group